Wells Fargo & Company MN trimmed its holdings in shares of Perrigo Company (NYSE:PRGO) by 35.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 134,341 shares of the company’s stock after selling 73,680 shares during the period. Wells Fargo & Company MN owned about 0.09% of Perrigo worth $10,145,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also modified their holdings of the company. Korea Investment CORP grew its holdings in Perrigo by 142.0% during the 2nd quarter. Korea Investment CORP now owns 1,331 shares of the company’s stock worth $101,000 after acquiring an additional 781 shares in the last quarter. Commonwealth Bank of Australia grew its holdings in Perrigo by 13.8% during the 2nd quarter. Commonwealth Bank of Australia now owns 1,455 shares of the company’s stock worth $108,000 after acquiring an additional 176 shares in the last quarter. Johnson Financial Group Inc. grew its holdings in Perrigo by 15.6% during the 1st quarter. Johnson Financial Group Inc. now owns 1,775 shares of the company’s stock worth $118,000 after acquiring an additional 240 shares in the last quarter. Bessemer Group Inc. grew its holdings in Perrigo by 1,046.2% during the 2nd quarter. Bessemer Group Inc. now owns 2,235 shares of the company’s stock worth $169,000 after acquiring an additional 2,040 shares in the last quarter. Finally, Global X Management Co. LLC grew its holdings in Perrigo by 56.4% during the 1st quarter. Global X Management Co. LLC now owns 2,370 shares of the company’s stock worth $157,000 after acquiring an additional 855 shares in the last quarter. Institutional investors own 82.44% of the company’s stock.

Shares of Perrigo Company (NYSE PRGO) opened at 86.69 on Thursday. The firm’s market capitalization is $12.36 billion. Perrigo Company has a 1-year low of $63.68 and a 1-year high of $96.20. The company has a 50-day moving average of $82.39 and a 200-day moving average of $74.53.

Perrigo (NYSE:PRGO) last announced its quarterly earnings results on Thursday, August 10th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.94 by $0.28. The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.18 billion. Perrigo had a positive return on equity of 11.55% and a negative net margin of 51.04%. The firm’s quarterly revenue was down 7.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.93 earnings per share. Equities research analysts predict that Perrigo Company will post $4.58 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Investors of record on Friday, August 25th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date was Wednesday, August 23rd. Perrigo’s dividend payout ratio (DPR) is -3.51%.

In related news, EVP Thomas Farrington sold 865 shares of the company’s stock in a transaction that occurred on Friday, August 18th. The stock was sold at an average price of $78.40, for a total value of $67,816.00. Following the completion of the transaction, the executive vice president now directly owns 2,870 shares of the company’s stock, valued at $225,008. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Jeffrey Needham sold 3,595 shares of the company’s stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $89.49, for a total value of $321,716.55. Following the completion of the transaction, the executive vice president now directly owns 10,118 shares of the company’s stock, valued at $905,459.82. The disclosure for this sale can be found here. Insiders sold 6,894 shares of company stock valued at $581,320 over the last ninety days. 6.90% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: “Wells Fargo & Company MN Sells 73,680 Shares of Perrigo Company (PRGO)” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at https://www.watchlistnews.com/wells-fargo-company-mn-sells-73680-shares-of-perrigo-company-prgo/1609270.html.

A number of analysts have recently weighed in on the stock. Canaccord Genuity restated a “buy” rating and issued a $100.00 price target (up from $88.00) on shares of Perrigo in a report on Wednesday, September 13th. Royal Bank Of Canada restated a “sell” rating and issued a $64.00 price target on shares of Perrigo in a report on Wednesday, September 13th. Deutsche Bank AG raised their price target on shares of Perrigo from $88.00 to $95.00 and gave the company a “buy” rating in a report on Thursday, September 14th. BidaskClub upgraded shares of Perrigo from a “sell” rating to a “hold” rating in a report on Saturday, September 16th. Finally, Cantor Fitzgerald raised their price target on shares of Perrigo from $93.00 to $107.00 and gave the company an “overweight” rating in a report on Tuesday, September 12th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and eight have assigned a buy rating to the company’s stock. Perrigo currently has an average rating of “Hold” and a consensus target price of $89.36.

About Perrigo

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related companies with Analyst Ratings Network's FREE daily email newsletter.